Hyperlipoproteinemias
Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
Subtype terms (5)
More specific conditions that are subtypes of Hyperlipoproteinemias in the MeSH hierarchy.
- Hyperlipoproteinemia Type I
12 drugs (7 approved, 5 experimental)
- Hyperlipoproteinemia Type II
43 drugs (21 approved, 22 experimental)
- Hyperlipoproteinemia Type III
7 drugs (6 approved, 1 experimental)
- Hyperlipoproteinemia Type IV
7 drugs (4 approved, 3 experimental)
- Hyperlipoproteinemia Type V
4 drugs (1 approved, 3 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 3 trials (8)
Phase 2 trials (4)
Organizations
Organization Involved with Phase 4 Indications (62)
- Daiichi Sankyo
- Takeda
- Amgen
- Kowa
- AstraZeneca
- Merck
- Pfizer
- Sanofi
- Dong-A Pharmaceutical
- GlaxoSmithKline
- JW Pharmaceutical
- Kos Pharmaceuticals
- Nordic Pharma Group
- Otsuka
- French National Agency for Research on AIDS and Viral Hepatitis
- National Heart, Lung, and Blood Institute (NHLBI)
- United States Army
- Ajou University
- University of London
- Harvard University
- Dong-A University
- Garvan Institute of Medical Research
- Harbin Medical University
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Korea University
- Kyung Hee University
- Osaka University
- Radboud University
- Radiant Research
- Seoul National University
- +32 more
Organization Involved with Phase 3 Indications (48)
- Abbott
- Bristol-Myers Squibb
- Eli Lilly
- Genzyme
- Shionogi
- Bayer
- Esperion Therapeutics
- HanAll BioPharma Co., Ltd.
- Ionis Pharmaceuticals, Inc.
- Kastle Therapeutics, LLC
- Kuhnil Pharmaceutical Co., Ltd.
- LG
- Solvay
- Daewoong Pharmaceutical Co. LTD.
- Genovate Biotechnology Co., Ltd.,
- IlDong Pharmaceutical Co Ltd
- Rottapharm
- Shahid Beheshti University of Medical Sciences
- Central South University
- Brown University
- Chang Gung University
- Gachon University
- National Yang-Ming University
- Stanford University
- Tufts University
- University of Miami
- University of Bonn
- University of Valencia
- Taichung Veterans General Hospital
- Taipei Medical University
- +18 more
Organization Involved with Phase 2 Indications (37)
- Furiex
- Kadmon
- Novartis
- Cortria Corporation
- Hengrui Therapeutics, Inc.
- Japan Tobacco Inc.
- LipimetiX Development, LLC
- CymaBay Therapeutics, Inc.
- PharmaNet
- Shanghai Junshi Bioscience Co.,Ltd.
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- National Center for Research Resources (NCRR)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Augusta University
- Bastyr University
- Emory University
- University of Washington
- Hamdard University
- National University of Malaysia
- Saint-Joseph University
- Linear Clinical Research
- Akros
- National Taiwan University
- Golden Biotechnology Corp.
- Catabasis
- University of Montreal
- Dr. Reddy's Laboratories
- University of Alabama, Birmingham
- TIMI Study Group, Boston, MA
- +7 more
Organization Involved with Phase 1 Indications (16)
- Silence Therapeutics GmbH
- Pharmena
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- New York University
- University of Guelph
- University of L'Aquila
- University of Tehran
- University of California, San Francisco
- Vanderbilt University
- Covance
- Medpace, Inc.
- Government of China
- University of North Carolina at Chapel Hill
- State University of New York, Buffalo
- Buffalo Clinical Research Center
- Gannex Pharma Co., Ltd.
Organization Involved with Other Experimental Indications (20)
- Healthy Drink Discoveries, Inc.
- Olive Lifesciences Pvt Ltd
- Huazhong University of Science and Technology
- Maine Center for Lipids and Cardiovascular Health
- Silesian University of Medicine
- Saarland University
- Hunan University of Traditional Chinese Medicine
- University of British Columbia
- University of Chester
- University of Copenhagen
- Sreenivasa Clinic Diabetic Research Center
- Boca Raton Community Hospital
- MAPS Applied Research Center
- Danish Child Cancer Foundation
- Pharmalogica
- Wearnes Biotech and Medicals
- Government of Poland
- University of Burgundy
- ZIVO Bioscience, Inc.
- Eastern Mediterranean University